Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Leukemia, Myeloid, Chronic-Phase × Interferon alpha-2 × 30 days × Clear all

Sponsor

Conditions

Melanoma 3 Neuroendocrine Tumors 1

Interventions

ponatinib 1 pembrolizumab 1 nilotinib 1 Practice Management, Medical 1 Interviews as Topic 1 Imatinib Mesylate 1 Dasatinib 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡